Showing results (451-460 of 468) with videos related to
Sort By:
Pageof 47
Neurology|March 17, 2000
Frequency and clinical determinants of dementia after ischemic strokeD W Desmond, J T Moroney, M C Paik, et al.Translational Psychiatry|May 16, 2013
Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP)C Reitz, G Tosto, B Vardarajan, et al.Journal of Clinical and Experimental Neuropsychology|November 30, 2000
Severe pain confounds neuropsychological test performanceE J Heyer, R Sharma, C J Winfree, et al.The Journal of Prevention of Alzheimer'S Disease|March 29, 2016
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS)A M Wessels, E R Siemers, P Yu, et al.European Journal of Neurology|February 2, 2011
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's diseaseR A Popat, S K Van Den Eeden, C M Tanner, et al.Journal of the Neurological Sciences|June 14, 2011
Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumV McGuire, S K Van Den Eeden, C M Tanner, et al.Neurology|December 15, 2004
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementiaJ J Sevigny, S M Albert, M P McDermott, et al.The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical TrialL S Schneider, D A Bennett, M R Farlow, et al.Molecular Psychiatry|March 14, 2019
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.Molecular Psychiatry|May 3, 2017
Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.Pageof 47